Ticker Details
Xeris Pharmaceuticals, Inc.
IPO Date:	June 22, 2018
Sector:	Healthcare
Market Cap:	$1.1B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 3.33%
Avg Daily Range (30 D):	$0.12 | 1.63%
Avg Daily Range (90 D):	$0.16 | 2.06%

Institutional Daily Volume
Avg Daily Volume:	1.48M
Avg Daily Volume (30 D):	1.34M
Avg Daily Volume (90 D):	1.93M

Trade Size
Avg Trade Size (Sh.):	211
Avg Trade Size (Sh.) (30 D):	98
Avg Trade Size (Sh.) (90 D):	110

Institutional Trades
Total Institutional Trades:	535
Avg Institutional Trade:	$1.77M
Avg Institutional Trade (30 D):	$1.25M
Avg Institutional Trade (90 D):	$1.77M
Avg Institutional Trade Volume:	.34M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.91M
Avg Closing Trade (30 D):	$1.27M
Avg Closing Trade (90 D):	$1.73M
Avg Closing Volume:	344.26K

News

Aug 7, 2025 @ 3:55 PM Xeris (XERS) Q2 Revenue Jumps 49% Source: Jesterai

May 9, 2024 @ 12:10 PM Xeris Biopharma (XERS) Reports Q1 Loss, Lags Reven... Source: Zacks Equity Research

Apr 17, 2024 @ 11:24 AM Strength Seen in MediWound (MDWD): Can Its 14.3% J... Source: Zacks Equity Research

Mar 30, 2024 @ 5:28 AM Xeris Biopharma: Checking-In On One Of My 'Top Ide... Source: Biologics

Mar 5, 2024 @ 2:42 PM Why Xeris (XERS) Might Surprise This Earnings Seas... Source: Zacks Equity Research

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$	$-.01	$-.06
Diluted EPS	$	$-.01	$-.06
Revenue	$74.38M	$71.54M	$60.12M
Gross Profit
Net Income / Loss	$.62M	$-1.93M	$-9.22M
Operating Income / Loss	$6.73M	$4.48M	$-3.09M
Cost of Revenue
Net Cash Flow	$32.21M	$.85M	$-13.18M
PE Ratio